Go to:
Logótipo
Comuta visibilidade da coluna esquerda
Você está em: Start > Publications > View > Caffeine consumption and mortality in chronic kidney disease: a nationally representative analysis
Publication

Publications

Caffeine consumption and mortality in chronic kidney disease: a nationally representative analysis

Title
Caffeine consumption and mortality in chronic kidney disease: a nationally representative analysis
Type
Article in International Scientific Journal
Year
2019
Authors
Vieira, MB
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Magrico, R
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Dias, CV
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Leitao, L
(Author)
Other
The person does not belong to the institution. The person does not belong to the institution. The person does not belong to the institution. Without AUTHENTICUS Without ORCID
Journal
Vol. 34
Pages: 974-980
ISSN: 0931-0509
Other information
Authenticus ID: P-00Q-PKE
Abstract (EN): Background An inverse relationship between coffee consumption and mortality has been reported in the general population. However, the association between caffeine consumption and mortality in patients with chronic kidney disease (CKD) remains uncertain. Methods We analysed 4863 non-institutionalized USA adults with CKD [defined by an estimated glomerular filtration rate (eGFR) of 15-60mL/min/1.73m(2) and/or a urinary albumin:creatinine ratio >30mg/g] in a nationwide study using the National Health and Nutrition Examination Survey (NHANES) 1999-2010. Caffeine consumption was evaluated by 24-h dietary recalls at baseline and all-cause, cardiovascular and cancer mortality were evaluated until 31 December 2011. We also performed an analysis of caffeine consumption according to its source (coffee, tea and soft drinks). Quartiles of caffeine consumption were <28.2mg/day (Q1), 28.2-103.0(Q2), 103.01-213.5(Q3) and >213.5 (Q4). Results During a median follow-up of 60months, 1283 participants died. Comparing with Q1 of caffeine consumption, the adjusted hazard ratio for all-cause mortality was 0.74 [95% confidence interval (CI) 0.60-0.91] for Q2, 0.74 (95% CI 0.62-0.89) for Q3 and 0.78 (95% CI 0.62-0.98) for Q4 (P=0.02 for trend across quartiles). There were no significant interactions between caffeine consumption quartiles and CKD stages or urinary albumin:creatinine ratio categories regarding all-cause mortality. Conclusions We detected an inverse association between caffeine consumption and all-cause mortality among participants with CKD.
Language: English
Type (Professor's evaluation): Scientific
No. of pages: 7
Documents
We could not find any documents associated to the publication.
Related Publications

Of the same authors

Risk-benefit profile of intensive blood pressure treatment (2018)
Another Publication in an International Scientific Journal
Neves, JS; Leitao, L; Magrico, R; Dias, CV; Vieira, MB
Renal Outcomes and the Relative Benefit and Harm of Intensive Treatment of Hypertension (2018)
Another Publication in an International Scientific Journal
Vieira, MB; Magrico, R; Dias, CV; Leitao, L; Neves, JS
Caffeine consumption and mortality in diabetes: an analysis of NHANES 1999-2010 (2017)
Other Publications
Neves, JS; Leitao, L; Magrico, R; Vieira, MB; Dias, CV; Oliveira, A; Carvalho, D
Lower free triiodothyronine levels within the reference range are associated with higher cardiovascular mortality: An analysis of the NHANES (2019)
Article in International Scientific Journal
Neves, JS; Leitao, L; Baptista, RB; Vieira, MB; Magrico, R; Dias, CV; Oliveira, A; Falcao Pires, I; Andre P Lourenco; Carvalho, Davide; Leite-Moreira AF
Impaired Fasting Glucose and Chronic Kidney Disease, Albuminuria, or Worsening Kidney Function: A Secondary Analysis of SPRINT (2019)
Article in International Scientific Journal
Vieira, MB; Neves, JS; Leitao, L; Baptista, RB; Magrico, R; Dias, CV; Oliveira, A; Carvalho, Davide; Mc Causland, FR

See all (6)

Of the same journal

The association between TNFRSF1B rs1061624 polymorphism and hypertension in end-stage kidney disease patients on dialysis (2024)
Another Publication in an International Scientific Journal
Belo, L; Santos-Silva, A; Catarino, C; Bronze da Rocha, E
Short-term effects of gadolinium and gadoteric acid on kidney – impact on inflammation (2024)
Another Publication in an International Scientific Journal
Belo, L; Santos-Silva, A; Catarino, C; Bronze da Rocha, E
Prolonged use of an intracardiac catheter for dialysis in a patient with multiple venous access failure (2006)
Another Publication in an International Scientific Journal
Santos Araujo, C; Casanova, J; Carvalho, B; Pestana M
Pharmacists' interventions in the management of patients with chronic kidney disease: a systematic review (2012)
Another Publication in an International Scientific Journal
Salgado, TM; Moles, R; Benrimoj, SI; Fernandez Llimos, F
Nephropathy in Fabry disease: the importance of early diagnosis and testing in high-risk populations (2009)
Another Publication in an International Scientific Journal
Oqvist, B; Brenner, BM; João Paulo Oliveira; Ortiz, A; Schaefer, R; Svarstad, E; Wanner, C; Zhang, K; Warnock, DG

See all (72)

Recommend this page Top
Copyright 1996-2025 © Faculdade de Direito da Universidade do Porto  I Terms and Conditions  I Acessibility  I Index A-Z
Page created on: 2025-08-09 at 15:57:01 | Privacy Policy | Personal Data Protection Policy | Whistleblowing